Business Trends– category –
-
Quantinuum Showcases Full-Stack Quantum Computing Platform and Roadmap Towards Universal, Fault-Tolerant Systems via New Video Release
Quantinuum (YouTube) USA Overview A YouTube video released on June 3, 2026, features Quantinuum as a leading full-stack quantum computing company, outlining its roadmap for building universal, fault-tolerant quantum computers. The compan... -
D-Wave Charts Gate-Model Roadmap Aiming for 100 Logical Qubits in Fault-Tolerant Quantum Computing by 2032
D-Wave Quantum Inc. Canada Overview D-Wave Quantum has unveiled a new gate-model roadmap to accelerate the development of commercial fault-tolerant quantum computing, targeting 100 logical qubits by 2032. This roadmap integrates D-Wave's... -
France’s Quobly Secures €115 Million ($133.5M) in Series A Funding to Accelerate Industrialization of Silicon Spin Quantum Processors for 2026 Commercial Launch
Founder Lodge France Overview French quantum computing startup Quobly has raised €115 million (approximately $133.5 million) in a Series A funding round led by Bpifrance, STMicroelectronics, and SEALSQ. This substantial investment aims t... -
Japan’s Largest Quantum Startup OptQC Secures ¥1.5 Billion, Revealing Vast Funding Gap with U.S. and Raising ‘Elpida-Style Failure Risk’ Concerns
note Japan Overview OptQC, Japan's largest quantum startup, raised ¥1.5 billion (approximately $10 million), highlighting a significant funding disparity compared to U.S. counterparts like PsiQuantum's $1 billion in 2025. This funding ga... -
AGC Biologics & Asimov Revolutionize Viral Vector Manufacturing with Single-Plasmid Lentiviral Edge Packaging Cell Line License
MetaphysicalCells Unknown Overview AGC Biologics and Asimov have licensed Asimov's pre-engineered Lentiviral (LV) Edge Packaging cell line, poised to revolutionize viral vector manufacturing. AGC Biologics' Milan facility can now produce... -
Terumo Unveils ‘Ecosystem Blueprint’ to Scale Cell Therapies in Asia, Integrating Workflow, Equipment, and Training
Regen Report Japan Overview Terumo has introduced a new 'Ecosystem Blueprint' aimed at supporting the scaling of cell therapies in the Asia-Pacific region. This strategy seeks to transition cell therapies from early development to scalab... -
Fujifilm Diosynth Biotechnologies Strengthens Technological Leadership in Cell Culture, Microbial Fermentation, Viral Vectors, and Cell Therapy Manufacturing
MabDesign France Overview Fujifilm Diosynth Biotechnologies is focused on combining its technological leadership with cGMP manufacturing facilities across key areas: cell culture, microbial fermentation, viral vectors, and cell therapy. ... -
ENCell Secures US Clinical Manufacturing Contract for Ingenium’s AML-Targeting NK Cell Therapy, ‘gengleucel’
KBR South Korea Overview ENCell, a CDMO specializing in cell and gene therapies, has secured a manufacturing contract for Ingenium Therapeutics' allogeneic NK cell therapy candidate, 'gengleucel,' for U.S. clinical trials. This therapy t... -
AGC Biologics Secures CDMO Contract with Teikoku Seiyaku for Recombinant rhMMP-7 Drug Substance, GMP Production at Chiba Plant
AGC Biologics Japan Overview AGC Biologics has signed a CDMO contract with Teikoku Seiyaku Co. for the microbial drug substance manufacturing of recombinant human matrix metalloproteinase-7 (rhMMP-7) 'KTP-001'. Initial cell bank creation... -
Hygenco Secures $105M, Including $50M from IFC, to Accelerate Green Hydrogen and Ammonia Production in India Towards 5 MMT by 2030 Target
Whalesbook India Overview Hygenco Green Energies has secured a $105 million investment, including $50 million from the IFC, to accelerate its green hydrogen and ammonia production efforts in India. The startup utilizes a 'gas-as-a-servic...
